About Innovaccer
Innovaccer provides a data activation platform that aggregates, analyzes, and leverages healthcare data to deliver actionable insights.
Headquarters
Innovaccer, San Francisco
Founded
2014-08-01
Industry
Analytics, Artificial Intelligence (AI), Database, Health Care
Last Funding Type
Series E
Valuation
3
Total Funding
$379.10 million dollars
IPO Status
Private
Financial
Innovaccer may be growing as evidenced by its recent product launches and competitive activities in the healthcare sector. The company unveiled a new medical AI scribe named Sara Scribe, aimed at assisting providers, which indicates an expansion of its product offerings. Additionally, Innovaccer launched an AI-Powered Healthcare Experience Platform (HXP) to enhance consumer experiences, demonstrating investment in innovation and the development of new technologies. Furthermore, the company is actively competing for provider contracts, as seen at the HIMSS24 event, suggesting that it is actively seeking new business opportunities and expanding its market presence.
Innovaccer Inc. is focused on enhancing data interoperability and analytics in healthcare. They are developing systems for the automatic display of contextually related data, which may streamline access to patient information. Their research includes a FaaS-based feature library using DAGs to optimize feature generation. Innovaccer is also working on unifying de-identified data from multiple sources, creating a global identifier to link disparate datasets. Additionally, they are refining column mappings with a byte level attention-based neural model, potentially improving data integration. Their efforts extend to automated health monitoring systems that assess health threats using individual and environmental datasets. These advancements aim to unify patient data and improve healthcare outcomes.
Innovaccer is in advanced talks to raise $250 million in new funding, potentially valuing the company at $2.5 billion to $3 billion. The company has also launched a quality management and reporting solution for health plans and announced a partnership with P3 Health Partners to enhance value-based care. Additionally, Innovaccer's technology will be used by GrayHawk Health to develop its healthcare experience platform.
Innovaccer Inc. is focused on enhancing data interoperability and analytics in healthcare. They are developing systems for the automatic display of contextually related data, which may streamline access to patient information. Their research includes a FaaS-based feature library using DAGs to optimize feature generation. Innovaccer is also working on unifying de-identified data from multiple sources, creating a global identifier to link disparate datasets. Additionally, they are refining column mappings with a byte level attention-based neural model, potentially improving data integration. Their efforts extend to automated health monitoring systems that assess health threats using individual and environmental datasets. These advancements aim to unify patient data and improve healthcare outcomes.
Innovaccer is in advanced talks to raise $250 million in new funding, potentially valuing the company at $2.5 billion to $3 billion. The company has also launched a quality management and reporting solution for health plans and announced a partnership with P3 Health Partners to enhance value-based care. Additionally, Innovaccer's technology will be used by GrayHawk Health to develop its healthcare experience platform.
Funding Rounds
7
Number of Lead Investors
5
Total Funding Amount
$379.10 million dollars
Number of Investors
24